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Background: Most signalling and regulatory proteins participate in transient protein-protein interactions during
biological processes. They usually serve as key regulators of various cellular processes and are often stable in both
protein-bound and unbound forms. Availability of high-resolution structures of their unbound and bound forms provides
an opportunity to understand the molecular mechanisms involved. In this work, we have addressed the question “What is
the nature, extent, location and functional significance of structural changes which are associated with formation of
protein-protein complexes?”
Results: A database of 76 non-redundant sets of high resolution 3-D structures of protein-protein complexes,
representing diverse functions, and corresponding unbound forms, has been used in this analysis. Structural changes
associated with protein-protein complexation have been investigated using structural measures and Protein Blocks
description. Our study highlights that significant structural rearrangement occurs on binding at the interface as well as at
regions away from the interface to form a highly specific, stable and functional complex. Notably, predominantly
unaltered interfaces interact mainly with interfaces undergoing substantial structural alterations, revealing the presence of
at least one structural regulatory component in every complex.
Interestingly, about one-half of the number of complexes, comprising largely of signalling proteins, show substantial
localized structural change at surfaces away from the interface. Normal mode analysis and available information on
functions on some of these complexes suggests that many of these changes are allosteric. This change is largely manifest
in the proteins whose interfaces are altered upon binding, implicating structural change as the possible trigger of
allosteric effect. Although large-scale studies of allostery induced by small-molecule effectors are available in literature, this
is, to our knowledge, the first study indicating the prevalence of allostery induced by protein effectors.
Conclusions: The enrichment of allosteric sites in signalling proteins, whose mutations commonly lead to diseases such
as cancer, provides support for the usage of allosteric modulators in combating these diseases.Background
Protein-protein interactions participate in myriad pro-
cesses of the cell such as replication, transcription,
translation, signal transduction, immune response, metab-
olism, membrane-associated processes and development
(e.g., [1-4]). Protein-protein interactions offer an excellent
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reproduction in any medium, provided the orto achieve large functional diversity using a limited genetic
repertoire [5]. Abnormal interactions between proteins
within the cell or from pathogens cause many human dis-
eases [6]. Protein binding can also elicit an allosteric
response. Allostery is an integral and pervasive mechan-
ism employed by nature to modulate cellular processes
[7-11]. It serves as a key mechanism for obtaining fine-
tuned regulation in several cellular processes – from
metabolic pathways, signalling systems [12] to gene regu-
lation [13]. Functional modulation is achieved either by
enhancing (positive co-operativity) or decreasing (negativel Ltd. This is an Open Access article distributed under the terms of the Creative
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iginal work is properly cited.
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can be varied, e.g., activation of catalysis, regulation of
ligand-binding, control of complex formation[9].
Given their importance, several high-throughput inter-
action assays [14,15], such as yeast two-hybrid and tandem
affinity purification, have been developed to supplement
the dataset of protein-protein interactions from low-
throughput methods [16,17]. However, such large-scale ex-
perimental methods suffer from high false-positive rates
[18]. The gold standard for protein-protein interactions is
usually a dataset of complexes of interacting proteins
solved using X-ray crystallography [19-21]. Although it is a
much smaller and incomplete dataset in comparison to
high-throughput protein-protein interaction datasets, it is
reliable and enables mapping of interaction regions and
structural changes which accompany interactions. Several
derived databases provide protein-protein interaction data-
sets in various easy to –study and –use formats. SCOPPI
[22], iPfam [23], SNAPPI-DB [24], 3D Complex [25],
InterEvol [26] and ProtCID [27] are some of the available
3D structural databases of protein-protein complexes.
Protein-protein interactions can be classified into dif-
ferent kinds [28]: homo-oligomers and hetero-oligomers;
obligate and non-obligate complexes; permanent and
transient complexes. Non-obligate complexes form an
important class since they serve as key regulators in
maintaining and regulating cellular homeostasis [29-31].
They are also valuable from the viewpoint of structural
biology since both the unbound and bound forms can
be crystallized owing to their stability. Several such
structures have been solved by various groups and
deposited in the Protein Data Bank (PDB) [32]. An in-
valuable non-redundant dataset of structures of both
the interacting partners solved in unbound and bound
form has been collated, curated and updated by Weng
and colleagues [33,34]. The ComSin database provides a
unique collection of structures of proteins solved in un-
bound and bound form, targeted towards disorder–
order transitions [35].
Earlier studies of structures of protein-protein com-
plexes using both the unbound and bound form of pro-
teins reveal that proteins undergo changes in their
structure upon binding. Betts and Sternberg [36] were
the first to compare the bound and unbound forms
using a dataset of 39 complexes. Martin et al. [37,38]
analyzed a dataset of 83 complexes in terms of local
structural variations. The alterations in structure as a re-
sult of protein-protein interactions manifest either as a
rigid-body shift of a segment or as a conformational
change from one secondary structural form to another
[39]. The extent of conformational change observed at
the interface upon binding prompted several studies to
understand and predict these changes [40-42]. Such
studies aim to improve protein-protein docking methods[43] and help in the accurate docking of protein-protein
interactions, which can be used to understand the mech-
anism of functioning of the complex or design inhibitors.
In this work, we have used a curated and non-redundant
dataset of 76 protein-protein complexes, solved using X-ray
crystallography in high resolution in both unbound and
bound form, to address questions about the nature, extent
and location of structural changes upon binding. We
noticed that, in addition to changes in the interface, pos-
sibly allosteric changes causing structural alteration occur
in about half of the complexes, indicating a much higher
prevalence of this phenomenon caused due to protein bind-
ing than appreciated before.
Results
Proteins bound to other proteins undergo larger
structural changes than unliganded proteins
Structural change observed in different forms of a protein
could be due to experimental artifacts [44], intrinsic flexibil-
ity [45] or due to a biologically important external perturb-
ation [46], such as ligand binding or post-translational
modification. To differentiate structural changes potentially
related to protein-protein interactions from those which
are artefacts, we compared variations occurring in the data-
set of protein-protein complexes with two control datasets
(see Additional file 1: Table S1). The first control set
(named Control – Rigid) consists of 50 structures, solved at
a resolution ≤2.5 Å, of two fairly rigid and extensively
studied proteins: bovine ribonuclease A and sperm whale
myoglobin, and provides an indicator of co-ordinate uncer-
tainties. The second control set (named Control – Mono-
mer) consists of a non-redundant set of 95 clusters of
structures of monomers, also solved at a resolution ≤2.5 Å,
which serve as a heterogeneous set since this dataset
contains both rigid and flexible proteins, thus serving as a
control set for understanding intrinsic flexibility. The main
dataset of our study named PPC (Protein-protein com-
plexes) is an extensively curated dataset of non-obligatory
proteins with their 3-D structures solved in both unbound
and bound forms (Additional file 2: Table S2). It consists of
76 non-obligatory complexes representing members of di-
verse functions (25 enzyme-inhibitor, 11 antigen-antibody
and 40 ‘other’ complexes, which largely comprises of signal-
ling proteins). The number of proteins involved in the 76
complexes represent the major SCOP (Structural Classifica-
tion of Proteins) [47] classes (all α - 32, all β - 84, α/β - 57,
α+β - 37). Since the dataset has been pruned to exclude
cases with a large percentage of missing residues at the
interface, disordered proteins are under-represented. The
complexes predominantly involve two-chain interactions
and some interactions involving three chains, in which two
chains are considered as a single entity (for example, in the
case of light and heavy chains of antibody and in the case
of Gβ-Gγ subunits in heterotrimeric G-proteins). The
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domain members. Although some of the structures in the
PPC dataset are solved at a resolution poorer than 2.5 Å,
the highest resolution of the Control-Rigid and Control-
Monomer datasets, the magnitude of structural changes
captured across the datasets can be compared since 50/76
complexes of the PPC dataset were solved with a resolution
≤2.5 Å. The conclusions of comparison of various para-
meters capturing structural change in the different datasets,
discussed below, remained unaltered when using either the
‘50’ or ‘76’ set of complexes (data not shown). The conclu-
sions described below are for the entire dataset of 76
complexes.
Three parameters were used to analyze structural
change occurring in the different types of residues (see
Methods) in a protein: root mean square deviation
(RMSD), %PB change (PBc), PB substitution score
(PBSSc). Although RMSD captures the magnitude of
structural change, it does not distinguish the type of
structural change – i.e. rigid body movement (or) con-
formational change. The use of Protein Blocks (PBs)
enables this distinction since small yet significant
changes in local conformation of a protein can be cap-
tured using PBs. Protein Blocks consists of 16 standard
conformational states of pentapeptides [48,49]. PBs can
be used to represent precisely backbone conformation of
all the protein structures known so far. This efficient de-
sign has been employed in several applications, including
prediction of long fragments and short loops, and in
identifying proteins with similar structures [49,50]. A PB
change between the unbound and bound forms for the
equivalent residue indicates a conformational change –
either subtle or drastic. The % PBs altered between two
structures serves as a metric for capturing the extent of
structural change (PBc). A substitution matrix derived
earlier [50] was used to calculate the magnitude of struc-
tural dissimilarity between two structures in terms of
their PB changes (namely PBSSc). A lower PBSSc indi-
cates unfavourable changes (i.e. drastic conformational
change – for example, a helix to a strand) whereas a
higher PBSSc indicates milder conformational changes
(for example, change between a curved helix and a linear
helix). Analysis of the three parameters revealed that all
types of residues (buried, surface, interacting) undergo
higher structural change upon binding to another pro-
tein than in the unliganded form (Figure 1). These
values are calculated at per-protein level for the different
classes of residues. RMSD (Figure 1A) and PBc
(Figure 1B) clearly showed higher structural variation of
protein-bound forms in comparison to the unbound
forms whereas PBSSc (Figure 1C) showed a marginal
trend. This is because the PB changes could be of two
kinds: favourable (high PBSSc) and unfavorable (low
PBSSc) and both are represented in the graph. Asexpected, buried residues showed the least deviation of
all the classes and interacting residues the highest
change. Buried residues are mostly invariant, as seen
from the box plot depicting the distribution of PBc
(Figure 1B), where ~50% of the values are zero for the
control datasets. Surprisingly, ~90% of buried residues
of protein-protein complex structures show at least a
single conformational change, as characterized by
change in PB (Figure 1B). However, the observed
changes are mostly minor. In the rare cases when it is a
large change, the residue is seen to have slight exposure
to solvent.
In order to distinguish structural variations caused due
to protein binding from those occurring due to crystallo-
graphic artifacts, the upper bound values corresponding
to the Control-Rigid dataset were used as reference for
the three parameters (see Additional file 3: Figure S1).
It is observed that the main protein-protein complex
dataset comprises of complexes with varying range of inter-
face area and size of proteins (see Additional file 2: Table
S2). Therefore, dependence of the parameters capturing
structural change for interface area and size of the protein
(represented as length of the protein) were analyzed. The
analysis indicates that there is slight dependence of RMSD,
PBc and PBSSc for interface area buried by the complex
whereas the parameters have negligible dependence on the
lengths of proteins (see Additional file 4: Figure S2).
Independently, we also captured structural change
using all-atom RMSD which includes consideration of
sidechain atoms. Although there is expected variation in
all-atom RMSDs for interacting residues (see Additional
file 5a: Figure S3), there is no profound variation when
the Cα RMSDs are compared with corresponding all-
atom RMSD values (see Additional file 5b: Figure S3).
Therefore, the present analysis is confined to Cα RMSD
based comparison in this study.
Pre-made interfaces predominantly bind to structurally-
altered interfaces
The extent of structural change at both the interfaces of
various complexes has been assessed. Proteins are classi-
fied into three categories based on the extent of
structural change at the interfaces of various complexes:
pre-made, induced-fit, and other. Interfaces exhibiting
Cα RMSD of <0.5 Å (which is the maximum deviation
between any two proteins of the Control-Rigid dataset)
are considered pre-made, while those with Cα RMSD of
>1.5 Å are considered induced-fit. The interfaces show-
ing structural changes between these two values are clas-
sified in the ‘other’ category. We identify 33 pre-made
interfaces, fitting the lock-and-key hypothesis proposed
to explain protein-ligand binding [51]. Such a large
number is surprising since the proteins would always be
primed for interaction. Nature’s regulatory control of the
Figure 1 Distribution of parameters capturing structural change for Control and Test datasets. Distribution of values for the parameters
A). Cα RMSD B). %PB changes and C). PB substitution scores calculated at a per-protein level for Control-Rigid, Control-Monomer and PPC
datasets. Buried residues are indicated with filled boxes. Ires - interacting residues; NonIres - non-interacting residues; Core_Res (≤5% RSA) -
buried residues; Surf10_RSA (>10% RSA) – surface residues. The figure shows that protein-protein complexes undergo significantly larger
structural changes when compared with unliganded forms for all residues types. The p-values for all of the following comparisons performed
using Mann–Whitney test indicates statistical significance (p-value< 0.0001) : M-All_Res vs. P-All_Res, M-Core_Res vs. P-Core_Res, and M-Surf10
_RSA vs. P-Surf10_RSA, for all the 3 parameters. This trend is prominently captured by the parameters Cα RMSD and %PB changesDistribution of
parameters capturing structural change for Control and Test datasets. Distribution of values for the parameters A). Cα RMSD B). %PB changes and
C).
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its partner interface. It appears that although one of the
interfaces is pre-made, the other interface undergoes
substantial changes (Figure 2A, blue coloured points) in
the final stable bound form (sometimes >1.5 Å Cα
RMSD, the cut-off for identifying ‘induced-fit’ inter-
faces). 9 protein-protein complexes, 5 from ‘Other’
category and 4 from Enzyme-Inhibitor category, show
this behaviour. 17 of the 33 pre-made interfaces had al-
most no PB changes, implying near complete absence of
conformational changes. However, the interaction seems
to be modulated by the structural changes occurring in
the partner interface. In 14/17 of these cases, the part-
ner’s PBc is >15%; in three cases it is >40% (Average
PBc is 26 ± 14). Only five of the 33 pairs seem to be pre-
made in both interfaces. However, inspection of PBc for
these ‘pre-made interfaces’ revealed that there are sub-
stantial conformational changes of smaller magnitude
captured using PBs which use atomic positions of N, C
and O atoms apart from Cα as opposed to Cα-based
RMSD (see Figure 2B). For instance, the complex of
cytochrome C peroxidise and iso-1-cytochrome C forms
a pre-made interface (see Additional file 6A: Figure S4),
with Cα RMSD of 0.37 Å and 0.31 Å for the interacting
proteins. However, the conformations of side chain posi-
tions of interface residues changes drastically in 3/18
interface residues. This example supports the hypothesis
that almost all interacting partners undergo changes
upon binding, even if one of the interfaces is pre-made,
and PBs help in identifying subtle changes than classicalRMSD measures. In essence, there are no ‘completely
pre-made’ interfaces.
Usually, interfaces with an average Cα RMSD of
≥1.5 Å showed substantial changes at interface, exempli-
fying the concept of induced-fit hypothesis [52] for for-
mation of protein-protein complexes (see Additional file
6B: Figure S4). 35 interfaces with average Cα RMSD of
≥1.5 Å are found. Of these predominantly altered inter-
faces, 10 are partners of pre-made interfaces, 4 are part-
ners of like-wise induced-fit interfaces and the rest have
values in between (see Additional file 6C,D: Figure S4).
Comparison of the structural change in terms of Cα
RMSD and normalized PB substitution score can help in
distinguishing cases of rigid body movements from con-
formational changes. Induced-fit interface regions with
0%PB change at interface can be considered to have
rigid-body movements (see Additional file 7A: Figure
S5). However, since PBs are very sensitive to backbone
torsion angle changes, two very similar PBs will also be
considered as PB changes. Therefore, normalized PB
substitution score is a more pertinent metric to grade
the local conformational change (see Additional file 7B:
Figure S5).
Large structural changes could result for different rea-
sons such as to avoid steric clashes and/or optimize
binding. In some cases, global changes in the molecule
(both interface and non-interacting surface RMSDs are
≥1.5 Å) are observed. These complexes either move out
(Figures 3A, Additional file 8E: Figure S6) (or) move in
(Additional file 8B: Figure S6) to relieve steric clashes/
Figure 2 Characteristics of different types of interfaces. The three kinds of interfaces are pre-made (blue color), induced-fit (brown) and
others (green). A). A plot of Cα RMSD for the pair of interacting partners is shown. Completely pre-made interfaces are enclosed in a yellow
square. B). The extent of conformational change for the three kinds of interfaces is shown. The graphs plot only the majority of the points (Cα
RMSD ≤6 Å) for the sake of clarity. This figure illustrates that A). Pre-made interfaces largely bind to induced-fit interfaces, and B). Although pre-
made interfaces show small magnitude of structural change, the extent of conformational change they undergo is comparable to that observed
in induced-fit/other interfaces. For both sets, points corresponding to complexes solved at a resolution >2.5 Å are encircled.
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were localized at the interface, comprising of rigid-body
movements (Additional file 8C: Figure S6) or conform-
ational changes (Additional file 8D: Figure S6) or
conformational changes with movement (Additional file
8A: Figure S6), to mainly optimize binding (Figure 3B)
or relieve steric clashes (Figure 3C) or both (Figure 3D).
Local rearrangements at the interface are identified
based on the normalization-based metric (see Methods
section). This criterion allows us to identify interfaces
with proportionately larger localized changes at the
interface although the magnitude is smaller (≤1.5 Å)
(Additional file 6D: Figure S4). In cases where thechange is larger (≥2 Å), rearrangement seems to be
mainly targeted at avoiding steric clashes. In cases where
the change is moderate (1.5 Å~ 2 Å), the rearrange-
ments appear to be mostly for proper optimization of
interface.
Non-interacting regions away from the interface undergo
substantial structural changes on binding
In general, interacting residues undergo larger structural
change than non-interacting surface residues (≥10% resi-
due surface accessibility (RSA)). Comparison of the three
parameters quantifying structural changes studied for indi-
vidual proteins showed that this trend holds true even in
Figure 3 Structural changes observed in interfaces. Protein undergoing change is shown as cartoon, with unbound form in light cyan and
the bound form in blue, and its partner as a ribbon, with unbound form in light orange and bound form in magenta. Direction of movement is
indicated as black arrow. A) Large (~10 Å Cα RMSD) moving out to avoid steric clash (alpha actin & BNI1 protein; 1Y64). B). Movement to optimise
interaction with partner (GTP binding protein & Rho GTPase activating protein; 1GRN). C). Conformational change accompanied by movement
mainly to avoid steric clashes with the partner (Glycoprotein Ib alpha & von Willebrand factor; 1 M10). In B) and C), the region of interest is
colored green and red in the unbound and bound forms, respectively. D). An interface (actin & deoxyribonuclease I; 1ATN) where certain region
moves away to avoid steric clash (colored in red), some region undergoes conformational change with movement to optimise an interaction
(depicted in green for the unbound form and brown for the bound form) and another region undergoes rigid body movement to optimise its
interaction (colored in lemon yellow in the unbound form and orange in the bound form). All the figures containing protein structures were
generated using PyMOL [77].
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interacting regions need to undergo rearrangement to
form an optimal fit. The general trend of comparatively
larger changes at interface regions was seen for RMSD
and PBSSc (see Additional file 9: Figure S7). However, the
parameter PBc provided a new insight, highlighting cases
with almost no conformational change at the interface but
with considerable change in the rest of the surface
(Figure 4, green ellipse). This emphasizes that there exist
complexes in which non-interacting regions undergo
structural variation upon binding even though the inter-
face remains largely unchanged. 6% of the complexes
exhibited 10%-25% PBc and one case showed 50% PBc in
the non-interacting surface region (Figure 4).Although interacting regions undergo large structural
changes in comparison to the rest of the surface, about
one-half of the cases in the PPC dataset reveal large
changes away from the interface (Figure 4, Tables 1 & 2).
PB changes in non-interfacial regions can be divided into
two cases. (i) Change in non-interacting regions even
when there are almost no changes in interacting regions
(n= 22) (Table 1). (ii) Change in non-interacting regions
accompanying changes in interacting regions (n= 12)
(Table 2). The two categories combine to provide a data-
set of 34/76 complexes exhibiting substantial structural
change in non-interfacial surface regions. Interfaces
represented in the first case can be considered as pre-
made since no PB change is observed on complexation.
Figure 4 Scatter plot of PBc for interacting residues vs. rest of
surface residues for PPC dataset. Proteins showing higher
proportion of PB changes at the interface are encircled in purple
whereas proteins showing PB changes in the non-interacting surface
region when the interacting region remains unaltered are encircled
in green. This plot reveals the existence of several protein-protein
complexes which exhibit substantial conformational changes at non-
interacting surface regions even though the interface region is
largely unmodified (shown in green circle).
Swapna et al. BMC Structural Biology 2012, 12:6 Page 7 of 21
http://www.biomedcentral.com/1472-6807/12/6As expected, the partner protein for these interfaces
exhibited much larger change at the interface.
Changes occurring in the non-interfacial regions are
classified as near the interface region or away from the
interface. All non-interfacial residues in a protein which
are within a distance of ≤6 Å Cα distance from any of
the interacting residues were considered as ‘residues
nearby interface’, since they occur in the vicinity of the
interfacial residues and are important for the formation
of the structural scaffold [53]. Figure 5 shows that in
most of the proteins, the residues nearby interface do
not undergo much change (Mean – 15.19%, Median –
12.31%); the highest peak is at 10%, which means that
most of the changes occurred away from the interface.
This fact was also confirmed by visual inspection of the
structure of the protein-protein complexes.
Conformational changes occurring away from the
interface are potentially allosteric: Literature-based,
structure-based and normal mode analysis
To ascertain any known or potential biological relevance
for these changes, all the ‘non-interacting regions with
PB change’ in the identified proteins were analyzed using
following parameters: (i) Crystallographic temperature
factor (B-factor). Regions with low flexibility and differ-
ent conformations are likely to have adopted the particu-
lar conformation. Studies report that interacting sites
have lower B-factors than rest of the protein surface onaverage even in the unbound form [54]. (ii) Known func-
tional roles of residues: SITE records listed in PDB files
and Catalytic Site Atlas (CSA) [55] were consulted to
identify if any of the known functionally important resi-
dues for the protein of interest are present in the non-
interacting regions with PB change. (iii) Literature
survey: Relevant literature of the crystal structures was
studied to check for any previously known information
about these observed PB changes for each protein. The
information gathered from the above sources is listed in
Table 3. The B-factor distribution for the non-
interacting residues with structural change varied from
‘low’ (normalized B-factor<−1, see Methods) to ‘very
high’ (normalized B-factor >3, see Methods) values. Un-
fortunately, PDB SITE records and CSA did not provide
information in most cases. Literature survey, although
unable to account for all the structural changes observed
in the non-interfacial region, indicates that many of
these changes are allosteric (15/34) [56-70].
We observed that most of the proteins with changes
are signalling proteins (17/22 in Case 1: Conformational
changes in non-interacting surface regions of proteins
with invariant interfaces & 8/12 in Case 2: Conform-
ational changes in non-interacting surface regions of
proteins with altered interfaces). Therefore, 25/40 ‘other’
complexes (predominantly signalling proteins) from the
PPC dataset show significant structural changes at distal
sites, indicating prevalence of this phenomenon in
signalling proteins. In contrast, only 7/25 and 3/11 com-
plexes of the enzyme-inhibitor and antigen-antibody
classes, respectively, show such changes.
Detailed information about the residue positions and
the nature of conformational change observed in the
residues possibly forming the target site for all examples
of Case 1 and Case 2 are listed in Additional file 10:
Table S3 & Additional file 11: Table S4, respectively.
Although literature studies implicate allosteric com-
munication to be the reason for the observed structural
changes away from the interface in nearly half of the
complexes, we did not get clues for the other cases.
Since flexibility of a region is known to be good indica-
tor of functional relevance [45], we used this as a metric
to identify the biological relevance of the structural
changes in all the cases. Coarse-grained normal mode
analysis (NMA) [71] is an effective and widely used
method to identify intrinsic dynamics of biomolecules at
equilibrium conditions solely based on their 3-D struc-
tures. This approach computes all possible vibrational
modes in which the molecule can move. Studies show
that biologically important functional motions are al-
most always captured within one or many low-frequency
modes, since they require the least energy for conform-
ational transitions [72]. Each mode indicates an intrinsic
tendency for collective reconfiguration at particular
Table 1 Features of proteins with substantial structural change in non-interacting regions and no/moderate change at
interface
PDB code Cα RMSD Normalized PB substitution score
Protein Bound Unbound IR* NIR_PBc* Difference IR* NIR_PBc* Difference
(NIR_PBc – IR) (NIR_PBc – IR)
PIP3 kinase (O) 1HE8_r 1E8Z 0.49 8.45 7.96 1.25 -1 -2.25
HISF protein (O) 1GPW_r 1THF 0.68 8.10 7.42 1.68 -1.31 -2.99
UCH-L3 (O) 1XD3_r 1UCH 1.30 5.11 3.80 1.35 -1.05 -2.4
Son of Sevenless (O) 1BKD_r 2II0 1.33 4.91 3.57 1.39 -0.82 -2.21
TGF-beta (O) 1KTZ_r 1TGK 0.66 4.41 3.75 2.1 -0.95 -3.05
HPr kinase C-ter domain (E) 1KKL_r 1JB1 1.76 4.00 2.24 1.95 -0.98 -2.93
Cystatin (E) 1YVB_l 1CEW 0.63 3.85 3.21 2.43 -1.24 -3.67
DH/PH domain of TRIO (O) 2NZ8_r 1NTY 1.33 3.77 2.43 1.25 -0.78 -2.03
Actin (O) 2BTF_r 1IJJ 1.08 3.77 2.68 1.76 -0.81 -2.57
Alpha-1-antitrypsin (E) 1OPH_r 1Q1P 0.92 3.50 2.58 1.35 -1.39 -2.74
TGFbeta receptor (O) 1B6C_l 1IAS 1.17 3.14 1.96 1.28 -1.04 -2.32
Vitamin D binding protein (O) 1KXP_l 1KW2 1.53 3.11 1.57 1.66 -0.77 -2.43
TolB (O) 2HQS_r 1CRZ 1.37 3.04 1.67 2 -0.81 -2.81
RCC1 (O) 1I2M_l 1A12 0.40 3.00 2.60 2.43 -0.99 -3.42
Sporulation response factor B (O) 1F51_r 1IXM 0.78 2.70 1.92 1.1 -0.97 -2.07
Ran GTPase (O) 1A2K_l 1QG4 0.33 2.57 2.24 2.56 -1.03 -3.59
HEW lysozyme (A) 1BVK_l 3LZT 0.31 2.57 2.25 2.86 -1.06 -3.92
Transferrin receptor ectodomain (O) 1DE4_l 1CX8 0.94 2.51 1.57 1.04 -1.16 -2.2
Anthrax toxin receptor (O) 1T6B_l 1SHU 0.27 2.32 2.05 2.15 -0.75 -2.9
Xylanase inhibitor (E) 2B42_r 1T6E 0.33 2.25 1.91 2.06 -0.95 -3.01
Fab (A) 1E6J_r 1E6O 0.75 1.98 1.22 2.48 -0.73 -3.21
Complement C3 (O) 1GHQ_r 1C3D 0.21 1.58 1.36 1.92 -0.69 -2.61
*The abbreviations used are: IR - Interface regions, NIR_PBc – Non-interacting regions with PB change, l – ligand (smaller of the two proteins in the complex), r –
receptor (bigger of the two proteins in the complex), E – enzyme-inhibitor complex, A – Antigen-antibody complex, O – Other complexes.
The proteins are listed in decreasing order of average Cα RMSD of NIR_PBc values. The average Cα RMSD of IR and NIR_PBc is 0.89 and 3.75, respectively. The
normalized PB substitution score for IR and NIR_PBc values is 1.78 and -0.98, respectively.
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ous aspects of structural biology, ranging from predic-
tion of functionally relevant motion in proteins and
assemblies, refinement of cryo-EM structures, identifica-
tion of notable evolutionarily conserved dynamic
patterns in protein families, to guiding protein docking
to proceed along trajectories deemed to be functionally
relevant [72,73]. Specifically, a study of four protein-
protein complexes using different variations of NMA to
identify the regions and directionality of structural
change revealed that these changes correlate with intrin-
sic motions of the protein in the unbound form [74]. A
Gaussian network model (GNM) –based NMA of the
unbound proteins in Case 1 and Case 2 sets that contain
‘non-interacting regions with PB change’ with low B-
factors in both unbound and bound forms were carried
out using oGNM web server, to identify regions exhibit-
ing intrinsic motion, which has largely been observed to
correlate with biologically relevant regions [75]. Asummary of the normal mode analysis results are pre-
sented in Table 4. NMA indicates that structural
changes away from the interface in some of the com-
plexes are functionally relevant. A study by Chennubho-
tla and Bahar indicates that a method that combines
information theoretic concepts with normal mode ana-
lysis can be used to determine the communication
mechanisms encoded in the structural topology of the
protein [76]. Based on these studies, allostery, which has
already been observed in 15/34 complexes according to
literature reports, appears to be the most likely mechan-
ism to explain the structural changes occurring at
regions away from the interface arising from protein
binding.
Apart from NMA, the extent of evolutionary conserva-
tion of these regions was also determined, using Jensen-
Shannon divergence measure. For regions where normal
mode analysis did not provide an indication of intrinsic
motion, we analyzed whether crystal packing effects could
Table 2 Proteins with substantial structural change in non-interacting regions and interfacial regions
PDB code Cα RMSD Differences from global RMSD Normalized PB
substitution score
Protein Bound Unbound IR* NIR_PBc* Global RMSD IR* – Global RMSD NIR_PBc* –
Global RMSD
IR* NIR_PBc*
Arf1 GTPase (O) 1R8S_r 1HUR 5.19 5.42 3.02 2.17 2.40 0.79 -0.67
Ras GTPase (O) 1BKD_l 1CTQ 4.39 4.43 2.21 2.18 2.22 0.63 -1.82
CDK2 kinase (E) 1FQ1_l 1B39 4.39 4.26 2.04 2.35 2.22 1.31 -1
FC fragment of human
IgG 1 (A)
1E4K_r 2DTQ 3.17 3.77 2.18 0.99 1.59 0.95 -0.99
Ran GTPase (O) 1I2M_r 1QG4 3.27 3.51 1.91 1.36 1.60 0.58 -0.8
Cystein protease (E) 1PXV_r 1X9Y 3.99 3.47 1.48 2.51 1.99 1.2 -1.04
Rab21 GTPase (O) 2OT3_l 1YZU 4.65 3.30 1.71 2.94 1.59 0.1 -0.6
CDC42 GTPase (O) 1GRN_r 1A4R 2.66 2.97 1 1.66 1.97 1.31 -0.96
Rac GTPase (O) 2NZ8_l 1MH1 3.87 2.68 1.17 2.70 1.51 -0.03 -1.18
Actin (O) 1ATN_r 1IJJ 6.09 2.58 1.54 4.55 1.04 0.97 -0.59
Rac GTPase (O) 1I4D_l 1MH1 2.31 2.52 0.81 1.50 1.71 1.15 -0.65
Glycoprotein IB-alpha (E) 1M10_l 1MOZ 3.95 2.12 0.89 3.06 1.23 0.91 -0.95
*The abbreviations used are: IR - Interface regions, NIR_PBc – Non-interacting regions with PB change, l – ligand (smaller of the two proteins in the complex),
r – receptor (bigger of the two proteins in the complex), E – enzyme-inhibitor complex, A – Antigen-antibody complex, O – Other complexes.
The proteins are listed in decreasing order of average Cα RMSD of NIR_PBc values. The average Cα RMSD of IR and NIR_PBc is 3.99 and 3.42, respectively. The
average difference in RMSD values for IR and NIR_PBc from global RMSD are 2.33 and 1.75, respectively. The normalized PB substitution score for IR and NIR_PBc
values is 1.737 and −0.95, respectively.
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determine this, symmetry-related molecules were gener-
ated for the bound and unbound molecule using PyMOL
[77], and checked to find any crystal packing which could
cause the change. A discussion of a few specific cases is
presented below.
a) TolB – Peptidoglycan associated lipoprotein (Pal)
complex. The proteins TolB and Pal constitute the
complex used by Escherichia coli and other ‘group A
colicins’ to penetrate and kill cells [78]. TolB protein
comprises of two domains – a smaller N-terminal
domain and a larger C-terminal β-propeller domain
which interacts with Pal protein. Large rigid-body
motions and conformational changes were seen far
away from the interface between the unbound and
bound forms of the TolB protein (Figure 6A,
encircled region). The biological relevance of these
changes is supported by experiments which prove
that Pal binding results in conformational changes
being transmitted to N terminal α/β domain of TolB
[79]. Further, a recent study shows that TolA binds
to the N-terminal region exhibiting structural
change in TolB [80], indicating that the structural
changes occurring upon Pal binding serves as an
allosteric signal. Additional support comes from
GNM-based normal mode analysis of the unbound
form. The region of our interest (mainly residues
86–91), was seen to have intrinsic tendency for
reconfiguration in the second most significant modepertaining to local motions (mode 3, Figure 6A,
purple coloured region). However, we identify that
this region is not evolutionary conserved and most
of the sites occurred in the least conserved bin of
residues in the protein.
b) Complement C3 and Epstein-Barr virus receptor C2
complex. Complement component C3d binds to
antigenic molecules. This binding helps in further
amplification of B cell responses as a consequence of
the simultaneous binding of antigen-bound C3d
with complement receptor type 2 and binding to B
cell receptor via bound antigen [81]. Complement
C3’s interaction with C2 receptor causes
conformational changes, identified using PBs, at
residues 264–274. No literature information specific
for this region was available. However, GNM
analysis of the unbound form indicated that the
region near to interface and the region in the
opposite side have intrinsic motion (Figure 6B,
purple coloured regions). The region of our interest
occurs opposite to the interface and is indicated to
be partly flexible, implying that this motion could be
biologically relevant (Figure 6B, green coloured
segment in purple coloured region). However, this
region is moderately conserved.
c) Ran GTPase and Regulator of chromosome
condensation (RCC1) complex. Ran GTPase is a key
component of G-protein signaling. It serves as a
molecular switch which cycles between GDP- and
GTP- bound states. It requires regulators for
Figure 5 Distribution of non-interacting residues with PB change. A). Histogram of “% of ‘residues nearby interface’ in a protein undergoing
PB change” is plotted. B). Histogram of “% of non-interacting residues with PB change” which are near to interface is plotted. The upper-bound
value for every range is indicated as the label on x-axis. This figure reveals that most of the conformational changes occurring in the non-
interacting surface regions are not near the interface.
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dissociation rates. Guanine nucleotide exchange
factors form the latter group which bind to G-
proteins and induce rapid dissociation of bound
GTP and hence enable fast activation to GTP bound
form. The structure under consideration is a
complex of Ran GTPase with the guanine nucleotide
exchange factor RCC1 [82].
Ran GTPase, which adopts the P-loop containing nu-
cleoside triphosphate hydrolases fold, contains two regions
of interest, one near the interface (residues 41–44) and the
other far away from the interface (residues 151–155)
(Figure 6C, encircled regions). The interface also under-
goes substantial changes on binding. The region of interest
near the interface is seen to be intrinsically mobile in the
second most important mode. The region of interest far
away from the interface is seen to be a part of a mobile re-
gion in the fourth important mode. This region is very
near to GDP-binding site in the unbound form. It appears
that binding of Ran GTPase and RCC1 causes structural
changes at distant sites (GDP-binding site) to bring about
exchange of nucleotides. This case provided a clear ex-
ample of signal transduction within the molecule to bringabout the desired biochemical effect. Such sites can also
probably be targeted by human intervention to prevent
disease manifestations, such as cancer in Ran signalling
pathway [83]. The sampling of homologous sequences was
not diverse enough to obtain a reliable answer about its
evolutionary conservation.
Structural changes away from the interface observed
largely in proteins with structurally altered interfaces
Since structural changes away from the interface appear
to be common on protein binding (n= 34/76), we stud-
ied the structures of the proteins in the complex to
understand if there are any common characteristics of
the protein exhibiting these changes (target protein) ver-
sus the binding partner (effector protein).
When we analysed the type of interface (pre-made,
induced-fit, other) in the target protein, we observe that
pre-made interfaces constitute only 7/34 complexes
undergoing structural changes away from the interface.
Induced-fit and moderately induced-fit (‘other’ inter-
faces) constitute the bulk, accounting for 15/34 and 13/
34 complexes, respectively. Allostery appears to be the
most plausible explanation to connect protein binding
with structural changes away from the interface, as
Table 3 Features of non-interacting regions with substantial conformational change upon protein-protein interaction
Protein B-factor PDB SITE record/Crystal atlas Crystal packing
Bound Unbound
Proteins with almost no structural change at the interface
PIP3 kinase (O) Poor resolution and
many missing residues
NI -
HISF protein (O) H H Catalytic site residues not present
in NIR_PBc/IR
-
UCH-L3 (O) Nh Nh Out of 4 active site residues,
one in IR
NIR_PBc is near IR
and are rigid in unbound form, one of
the symmetry-related molecules is
situated ~6Å towards this region.
Son of Sevenless (O) H Nh NI -
TGF-beta (O) Missing residues near this
region
NI -
HPr kinase C-ter domain (E) Resolution of PDBs is 2.8 Å NI -
Cystatin (E) H H NI -
DH/PH domain of TRIO (O) Temperature factors for region
under consideration abnormally high!
NI -
Actin (O) H Not so high 4/12 important residues are
present in NIR_PBc
Region involved in dimerization in
unbound form
Alpha-1-antitrypsin (E) H H Important residues present in IR -
TGFbeta receptor (O) Nh Nh 3/5 of active site residues are present
in NIR_PBc
-
Vitamin D binding protein (O) Nh Nh NI NIR_PBc values are close to the ones
observed are IR and rigid in unbound
form, one of the 4 symmetry-related
molecules comes ~7Å towards this region.
Another NIR_PBc value is far away from IR
and is slightly mobile - the same
symmetry-related molecule comes <5Å
close to this region!
TolB (O) Nh H NI -
Ran GTPase (O) Nh (nearby IR), H H, Nh NI -
Sporulation response
factor B (O)
Missing residues near this region NI -
Ran GTPase (O) H Nh One important residue present in IR -





Poor resolution. Important residues not present
in IR/NIR_PBc
-
Anthrax toxin receptor (O) Missing residues near this region NI -
Xylanase inhibitor (E) H H Catalytic site residues not present
in NIR_PBc/IR
-
Fab (A) H Very high NI -
Complement C3 (O) Nh Nh Important residues are not present
in NIR_PBc/IR
-
Proteins with substantial structural change at interface
Arf1 GTPase (O) Nh Nh - -
Ran GTPase (O) Nh Nh Important residues are present
in NIR_PBC/IR
-
*The abbreviations used are: IR - Interface regions, NIR_PBc – Non-interacting regions with PB change, H- High, Nh – Not high, E – Enz-Inh complex, A – Ag-Ab
complex, O – Other complex, NI – No information.
# The NIR_PBc in this protein are near to IR.
Rows formatted as bold + italics are the ones considered for in-depth analysis since they have reasonably low B-factors at particular regions of NIR_PBc or have
functionally important residues present in IR/NIR_PBc.
Cases with B-factor ≥2, ≥3, and <1 standard deviation from mean are indicated as ‘high’, ‘very high’, and ‘low’, respectively.
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Table 4 Results of normal mode analysis for proteins with ‘non-interacting regions with PB change’
PDBcode Region of interest Mobile/Rigid? Whole/Embedded Mode
Cases with substantial change in non-interacting residues whereas interacting region has very less change
2HQS:A Interface region Highly mobile Whole 5
NIR_PBc far away (mainly 86-91) Highly mobile Whole 3
1GHQ:A Interface region Highly mobile Whole 1
NIR_PBc far away (264-274) Partially mobile Embedded 1
1OPH:A Interface region Highly mobile Whole 1
NIR_PBc far away (120-123) Mobile Embedded 1
NIR_PBc near interface (191-194) Mobile Embedded 1
1KXP:D Interface region Rigid - -
NIR_PBc far away (314-325) Low mobility Embedded 1
NIR_PBc near interface (250-258) Rigid - -
2BTF:A Interface region Rigid - -
NIR_PBc far away (156-158) Rigid - -
1XD3:A Interface region Partly mobile Embedded 2
NIR_PBc near interface (89-93) Rigid - -
1BVK:F Interface region Partly mobile Whole 1
NIR_PBc with interface (100-105) Mobile Embedded 2
1B6C:B Interface region Rigid - -
NIR_PBc near interface (15-22) Mobile Whole 3
NIR_PBc near interface (152-157) Mobile Embedded 4
Cases with substantial change in non-interacting residues near interacting region as well as in interacting region
1I2M:A Interface region Rigid - -
NIR_PBc far away (145-149) Mobile Embedded 4
NIR_PBc near interface (32-29) Partly mobile Embedded 2
*The abbreviations used are: IR - Interface regions, NIR_PBc – Non-interacting regions with PB change.
This table lists the results of the analysis using NMA regarding the intrinsic tendency for regions of interest to be rigid or mobile. The term ‘Embedded’ indicates
that the region under consideration possesses intrinsic mobility as part of a segment, whereas the term ‘Whole’ indicates that the region is independent. NIR_PBc
which are indicated to be mobile are shown in bold formatting and those indicated to be rigid are italicized. Note that the PDB codes and chains provided are for
the bound form whereas the corresponding unbound form structure was used for NMA.
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proteins comprising of pre-made interfaces (26/33) do
not appear to be the target proteins involved in allosteric
communication. On the contrary, they seem to serve as
the effector molecules for transmitting the allosteric sig-
nal to the partner protein. Comparison of the global
RMSDs of case 1 complexes indicates that the target
proteins (Cα RMSD=1.52 ± 0.71 Å) are significantly
more flexible than their effector proteins (Cα RMSD of
0.86 ± 0.60 Å with a p value of 0.0018 for a Wilcoxon
paired test). However, the disparity in the values could
be partly caused due to the differences in lengths
(effector - 183 ± 91, target - 389 ± 247, Wilcoxon paired
test p value - 0.0006) since RMSD is dependent on the
number of residues. For proteins of case 2 complexes,
there is no significant variation in terms of their lengths
(Effector proteins – 236 ± 105, Target proteins – 245 ±
88, Wilcoxon paired test p value – 0.73). However, the
global RMSDs of the target proteins (1.65 ± 0.64) areslightly yet significantly higher than those of the effector
proteins (1.04 ± 0.67) (p value – 0.0342, Wilcoxon paired
test). Therefore, it appears that binding of an effector
protein causes changes at the interface of the target
protein that are propagated towards the distant allosteric
site, providing credence to the views implicating flexibil-
ity in allosteric modulation [84].
Discussion
Availability of bound and unbound structures of proteins
provides an opportunity to address various questions
regarding structural alterations occurring due to
protein-protein interactions. Our study underlines that
macromolecular liganded forms of proteins undergo
larger structural alterations in terms of change in local
conformation (captured using PBs) as well as atomic
positions (captured using RMSD) compared to unli-
ganded proteins (Figure 1). These changes are much
larger than those observed due to random fluctuations
Figure 6 Normal mode analysis of structural changes in regions of low B-factor away from interface. The protein containing region of
interest is depicted as cartoon and the interface of other protein in ribbon. Unbound and bound form of the protein of interest is coloured pale
cyan and marine blue, respectively. The partner protein’s unbound and bound forms are coloured light orange and yellow, respectively.
Interacting residues are coloured in red and non-interacting residues with PB change in green. All regions of interest are marked with a black
circle, irrespective of whether they are intrinsically mobile or rigid. Regions identified to be intrinsically mobile according to NMA are coloured
violet. Regions of interest occurring within the intrinsically mobile segments are coloured in dark green. The complexes shown are A). TolB – PAL
complex (2HQS) B). Complement C3 and Epstein-Barr virus receptor C2 complex (1GHQ) C). Ran GTPase and Regulator of chromosome
condensation (RCC1) complex (1I2M). The partner containing the region of interest is represented in italics. These figures show that non-
interacting regions observed to undergo conformational changes upon complexation are usually intrinsically mobile, which is a characteristic of a
functional site.
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facts (see Additional file 3: Figure S1).
Non-obligatory complexes occupy a niche position as
key regulators of cellular homeostasis. Their specific and
timely association and dissociation are crucial for bring-
ing about required biological function. Spatial and tem-
poral regulation of the interacting proteins is one of the
ways of avoiding unsuitable complexation [85]. The
other mechanism could be the use of different confor-
mations of binding sites, which provide favourable or
unfavourable binding-competence to the partner.
Transformation of binding site structure into the active
form can serve as a switch to ensure correct binding at
the appropriate time. Our analysis of structural alterations
provides credence to this view. Surprisingly, pre-made
interfaces, which are structurally invariant upon binding,
shows distribution of %PB changes similar to that
observed for induced-fit interfaces. This indicates that
there is some extent of conformational change in all inter-
faces; only the nature and magnitude varies (Figure 2B).
Additionally, interface of the partner of pre-made interface
is usually observed to undergo significant structural
changes (Figure 2A). In essence, there are no ‘completely
pre-made’ interfaces in non-obligatory complexes. Cru-
cially, significant structural changes are observed at back-
bone level in most of the interfaces used in this study. It is
well known that side-chains undergo large structural
changes upon protein-protein complexation [86]. Consid-
ered together, these results support the view that struc-
tural conformations by themselves can serve as a good
mechanism to implement the required tight regulation.
Lower magnitude of structural changes is generally
observed to optimize complex formation, whereas larger
magnitude of structural changes is observed to remove
steric clashes.
We also observe a substantial proportion of instances
with significant conformational changes in non-interacting
regions away from the interface (Figure 4). Identification of
these cases is facilitated by the ability of PBs to capture sub-
tle structural variations. Observation of structural changes
away from interface changes has been reported previously
[87-89]. They could be due to various factors:
1. Flexible regions are dynamic and can take up several
distinct conformations, which can have specific
functional relevance [45]. Several studies have
revealed that flexibility is localized to certain regions
of protein structure and such dynamic sites are
usually involved in both small and large molecular
interaction [90,91] and enzymatic catalysis. In our
study, the interface regions of TolB - Pal complex
(Figure 6A) and Complement C3 - Epstein-Barr
virus receptor C2 complex (Figure 6B) are shown by
normal mode analysis to be intrinsically mobile.2. Studies show that thermodynamic entropy
redistribution is a common outcome of protein-
protein interaction, irrespective of the net change in
entropy after complexation [92]. Loss of entropy at
interacting sites is many times accompanied by gain
of entropy in other regions of surface. ‘Entropy-
entropy compensation’ may be due to significant
intermolecular motion between the interacting
molecules, which recovers about half of the entropy
lost due to rotational and translational components
[92]. This compensatory mechanism has been
postulated to be the mechanism responsible for
high-specificity binding of multiple ligands at the
same region of a protein.
3. The region may be functionally relevant, for e.g. a
ligand/macromolecule binding site, whose
conformation is regulated by an allosteric
mechanism. Since binding sites are observed to be a
combination of flexible and rigid sites [90], the
signal based on protein-protein complexation may
alter the stability and facilitate conformational
change at the functionally relevant distant region.
The complex of Ran GTPase with its cognate
guanine nucleotide exchange factor probably utilizes
this mechanism since complexation helps in altering
the accessibility to the ligand on Rho protein
(Figure 6C).
4. Crystallization is known to induce substantially
altered conformations [44]. In our study, we ensure
that this bias is accounted for (Table 3) and that the
conformational changes observed are not due to
such effects.
5. Trivial factors, such as missing residues near the
region of interest (or) the region being near termini,
could contribute to such changes [93]. Since we
ruled out complexes exhibiting such changes
(Table 3), the changes observed have other biological
origin.
In-depth analysis of several complexes using rigor-
ous coarse-grained NMA and literature survey indi-
cates that a fair proportion of structural changes
upon protein-protein complexation are allosteric
(Figure 6, Tables 4). Such communication is largely
enriched in signalling proteins, which seems plausible
considering the complex regulation of signal trans-
duction pathways achieved using the interplay of sev-
eral modular elements [12]. The lesser frequency of
occurrence of such changes in enzyme-inhibitor and
antibody-antigen complexes is expected. In the case
of the former, their interaction is usually the result of
an allosteric modulation and in the latter, a very
high-affinity complex is formed, which needs to be
cleared.
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fector binding causing functionally relevant conform-
ational changes at a distant site [10]. The salient features
of the models involves two key attributes: the presence
of two conformational states of the protein, one stabi-
lised in the unbound state and the other favoured upon
binding of the allosteric effector, and induction of struc-
tural change at the target site leading to functional
modulation. However, studies in the last two decades
have thrown new light on this phenomenon. The obser-
vations of allosteric modulation in the absence of con-
formational change [94] and the introduction of
allosteric perturbation in non-allosteric proteins [95]
have raised the viewpoint that all dynamic proteins are
possibly allosteric [96]. These studies indicate that pro-
teins in their unbound states exist in several conform-
ational sub-states, characterized by different population
densities [97]. Allosteric perturbation results in change
in the relative populations of these conformers [98].
Such studies resulted in a paradigm shift in the under-
standing of allostery from a structure-centric to a
thermodynamics-centric phenomenon [98]. Although
newer studies on allostery indicate that change in dy-
namics also enables allosteric communication in many
cases [94-96,98,99], in this study we have confined our-
selves to the study of allostery in the classical sense, as
communicated by structural changes. Surprisingly, allo-
steric communication established only via structural
changes appears to be established in almost half of the
complexes upon protein binding. Consideration of dy-
namics along with structural changes would most prob-
ably lead to uncovering of many more protein-induced
allosteric changes. Therefore, our study suggests that
protein-protein binding in the case of signalling com-
plexes, is often likely to result in downstream effects.
The smaller of the two proteins in a complex, usually
comprising of an unaltered interface upon protein-
protein complexation, appears to be the effector mol-
ecule in most cases. The binding event generally causes
changes at the interface and concomitant structural
changes at the target site.
Signalling proteins are key drug targets and the usage
of allosteric modulators as drugs is gaining acceptance
[100,101]. In such a scenario, the understanding that
most protein-protein interactions in signalling proteins
are allosteric provides impetus for the design of allo-
steric modulators as drugs. Allosteric regulators provide
certain advantages over traditional drugs, which are usu-
ally competitive inhibitors. Binding of an allosteric drug
at a distant site provides reduced side-effects, saturabil-
ity, modulation in the presence of true agonist etc.
[84,100]. We hope that knowledge of possible allosteri-
cally modified sites identified in the signalling complexes
studied in our analysis (see Additional file 10: Table S3& Additional file 11: Table S4) serves as a starting point
for combating disease manifestations.
Conclusions
Comparison of bound and unbound structures of
protein-protein complexes enables us to address various
questions regarding structural alterations occurring due
to interaction. Non-obligatory complexes occupy a niche
position as key regulators of cellular homeostasis with
appropriate and timely association and dissociation
which are crucial for eliciting the necessary biological
function. Structural alterations in most of the interfaces
of these non-obligatory complexes support the view that
conformational features by themselves can serve as a
good mechanism to implement the required tight
regulation.
The interface is the most altered region in the entire
protein structure upon protein-protein binding, as
expected. The modifications are largely conformational
in nature. In the rare case of one the partners remaining
unaltered, the other partner is usually observed to
undergo significant structural modification, thereby sup-
porting the ‘induced fit hypothesis’ [52] more than the
‘lock and key hypothesis’ [51].
The observation of a substantial proportion of instances
with significant structural changes in non-interacting
regions away from the interface implies that the binding is
likely to result in downstream effects. In-depth analysis of
several complexes using rigorous coarse-grained NMA
and literature survey indicates that these changes have
functional relevance, with most of them being allosteric.
The observation of allostery-like structural changes in
about half of the transient complexes suggests this
phenomenon is much more prevalent in signalling com-
plexes than appreciated before. It also appears that the
reversible nature of protein-protein association and dis-
sociation, characteristic of transient complexes, affords na-
ture with an attractive means to bring about allostery
which is generally a reversible process.
Methods
Datasets used
Two kinds of control datasets are used.
a) Rigid-proteins dataset (Control dataset 1): A dataset
of 50 independently determined structures of two
rigid proteins (see Additional file 1: Table S1),
bovine ribonuclease (32 structures) and sperm whale
myoglobin (18 structures), were taken from Rashin
et.al [44]. Values calculated from this dataset for
different parameters are used as thresholds to
account for positional coordinate uncertainty.
b) Monomeric-proteins dataset (Control dataset 2): To
get a general idea about the flexibility in atomic
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for crystal structures of proteins with the following
criteria: a single chain is present in the asymmetric
unit and biological unit; crystallographic resolution
of the structure should be 2.5 Å or better and the
structure should not contain DNA, RNA, DNA-
RNA hybrid, or other ligands bound to the protein.
These molecules were clustered at a sequence
identity of 95% and length coverage of 100% using
BLASTCLUST (http://www.csc.fi/english/research/
sciences/bioscience/programs/blast/blastclust).
Finally, the clusters were refined to contain only one
entry for each PubmedID per cluster, which ensures
that mutants are not considered, to arrive at a
dataset containing 95 clusters (see Additional file 2:
Table S2) of 319 independently solved protein
structures.
Protein-protein complex (PPC) dataset
The set of curated non-obligatory protein-protein inter-
action complexes solved in both unbound and bound
form is taken from Benchmark 3.0 dataset [34]. The set
was further pruned using PISA [102] and PDB biological
unit information to exclude cases containing different
non-biological oligomeric forms of a protein in the un-
bound and bound forms (eg. X-X in unbound form and
X-Y in bound form) and bound to other small ligands or
peptides. All antibody-antigen complexes in the original
dataset in which only the bound structure of the anti-
body was solved were discarded since the corresponding
unbound form was not available. The final dataset con-
sists of 76 non-obligatory complexes (see Additional file
2: Table S2). The resolution of these entries is 3.5 Å or
better. Proteins in every interacting pair in the dataset is
non-redundant at the level of SCOP family [47]. Al-
though a much larger dataset can be compiled if only
one of the interacting proteins is available in unbound
and bound form, such a dataset was not used since our
objective is to compare the changes occurring in both
the proteins upon complexation.
Although our dataset is intended to contain entries of
identical proteins or protein domains available in both
protein-bound and free forms, practically there could be
some differences in the length and region of known 3-D
structures in the bound and free forms. However the
overwhelming majority of the same protein available in
bound and free forms have >90% sequence identity (see
Additional file 2: Table S2) indicating that the bound
and unbound forms are almost the same. In all the cases
with % sequence identity less than 90%, it is observed
that the aligned region is identical or contains very few
substitutions. Further, of the 3 cases showing large
length variation between the bound and unbound forms
(PDB codes: 1gcq, 1qa9, 1e6j) only 1e6j features in ouranalysis of cases showing structural changes away from
the interface. So, it appears that the analysis is robust to
length variations between bound and unbound forms of
a protein.
As mentioned before the dataset used in the present
analysis was derived from the robust list of protein-
protein complexes proposed by Weng and coworkers
[34] in their protein-protein docking benchmark version
3.0. In this dataset the authors have carefully avoided the
complexes with significant extent of disordered regions.
Indeed in the dataset used in the current analysis none
of the complex structures used has any disordered resi-
due at the protein-protein interfaces. This could be
ensured on the basis of information on missing residues
given in the PDB file, by checking the distance between
Cα atoms of putative adjacent residues and by checking
for the presence of all the expected atoms in a residue.
Identification of interfacial residues
If the distance between any two atoms of residues from
the two proteins is less than sum of their van der Waals
radii + 0.5 Å, the two residues are considered to be in
the interface [53]. The van der Waals radii were taken
from the literature [103].
Classification of residues based on solvent accessibility
The residues in a structure are classified on the basis of
their residue surface accessibility (RSA) which is calculated
using NACCESS [104,105]. This parameter provides a
normalized measure of the accessible surface area of any
residue in the protein, calculated with respect to the
extended form of the residue, using the NACCESS
program. The cut-offs employed are: ≤5% RSA (buried
residues) and ≥10% RSA (surface residues). The 5% cut-off
was adopted from [106], who optimized and used it to
define residues buried in monomeric proteins. Buried, sur-
face, and interface residues constitute ~25%, 75% and 10-
20% of the residues in a protein, respectively.Quantification of structural change
Structural change is estimated for a given residue in
unbound and bound forms. A sequence alignment of
the unbound and bound forms performed using
CLUSTALW [107] provides the residue equivalences.
Structural change is captured using two measures:
RMSD and Protein Blocks. Structural change is clas-
sically captured by means of root mean square devi-
ation (RMSD), where RMSD is calculated as follows:
RMSD ¼ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ1=N∑di2p for i ranging from residue 1 to
n of the dataset and d is the distance between N
pairs of equivalent atoms. Two measures of RMSD
have been employed: Cα RMSD and all-atom RMSD,
based on deviation between the Cα positions of the
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former and between all-atoms of the same residue in
unbound and bound forms for the latter. Deviation
in side chain positions are generally expected [86]
whereas large backbone changes are comparatively
uncommon. Therefore, the deviation between the Cα
positions of the same residue in unbound and bound
form is used as an indicator of structural change
mainly. The changes are captured at structural level
and averaged out for the entire protein or a set of
residues in a protein (for e.g. interface residues) and
the averaged measures are used in the analysis. Small
yet significant changes in local conformation of a
protein can be captured using Protein Blocks [48].
The three dimensional structural information in the
bound and unbound forms is represented in a one-
dimensional form using Protein Blocks (PBs). They
consist of 16 structural prototypes, each of which
approximates the backbone of a five-residue peptide.
Given a 3D structure, each overlapping sequence of
5-residue fragments is associated with its closest PB.
The sequence of PBs is annotated in the sequence
alignment obtained using CLUSTALW. Two para-
meters are calculated using this measure. The first
parameter indicates the presence of conformational
change and is calculated as % changes in PBs between
unbound and bound form (PBc). The second param-
eter indicates the magnitude of observed change and
is calculated using PB substitution score (PBSSc) for
the equivalent residues.
‘Pre-made’ versus ‘induced-fit’ interfaces
An interface with ≥0.5 Å Cα RMSD difference be-
tween the bound and unbound forms is classified as
‘pre-made’ interface whereas an interface with ≥1.5 Å
Cα RMSD difference between the bound and un-
bound forms is classified as an ‘induced-fit’ interface.
However, there are some interfaces with lower differ-
ence in terms of magnitude but with substantial dif-
ference at the interface in comparison to the rest of
the surface residues (≥10% RSA). This cut-off was
chosen since 90% of the interface residues have an
RSA equal to or greater than this value in the un-
bound form. A normalization-based metric was used
to identify induced-fit interfaces exhibiting smaller
structural changes as N ¼ CαRMSDICαRMSDROS where ‘CαRMSDI’
indicates the average Cα RMSD difference between
bound and unbound form for interface, and ‘CαRMS-
DROS’ indicates the average Cα RMSD difference be-
tween bound and unbound form for the rest of the
surface.
For example, a value of two indicates a doubled
change in magnitude of the interface with respect tothe rest of the surface. This value is used as a cut-off
to identify substantial changes localized to the
interface.
Identification of proteins with substantial structural
change in non-interacting regions
To identify cases where the interface is largely invariant/
moderately altered:
Criterion 1: Average Cα RMSD of ‘non-interacting
residues with PB change’ should be ≥1 Å than the
average Cα RMSD of the interface residues. For this
comparison, the individual segments under
consideration, were superimposed using SUPER (B.S.
Neela, unpublished).
Criterion 2: Normalized PB substitution score of ‘non-
interacting residues with PB change’ should be ≤−2
than the normalized PB substitution score of
interacting residues.
To identify cases where there are large changes at
interface:
Criterion 1: Average Cα RMSD of both ‘non-interacting
residues with PB change’ and interacting region should
be ≥2 Å.
Criterion 2: Average Cα RMSD of both ‘non-interacting
residues with PB change’ and interacting region should
be >> global Cα RMSD.
Analysis of B-factors
The B-factor (temperature factor/atomic displace-
ment factor) of an atom reflects the degree of iso-
tropic smearing of electron density around its center
[108]. A low B-factor indicates small uncertainty in
the position of an atom. A high B-factor can be
caused by different factors: high thermal fluctuations,
alternate conformation of an atom, and domain mo-
tion, to name a few.
To ascertain the flexibility/rigidity of a particular
residue in a structure, its normalized backbone B-
factor was considered [109]. Normalization with re-
spect to all the other residues provides an idea of in-
crease/decrease in flexibility on a standard scale. Only
surface residues (≥10% RSA) were considered for the
normalization since all interacting residues and non-
interacting surface residues form the crux of this
study. The three most N-terminal and C-terminal sur-
face residues were excluded since their B-factors are
usually high and can affect the ‘mean’ of the values.
B-factors of only backbone atoms were considered as
we are studying backbone changes and also since side
chain are generally more flexible than backbone
atoms. The normalized B-factor per residue (Bi,N) was
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residue i, <Bi> is the mean B-factor of the protein
surface residues and σ Bi is the s.d. for the same.
Residues with backbone B-factors ≥3, ≥2, and <1
standard deviations from the mean backbone B-factors
for surface residues can be considered to have ‘very high’,
‘high’ and ‘low’ flexibility, respectively.
Identification of regions of protein structure with intrinsic
collective motions
GNM-based NMA of the unbound form of a protein
was undertaken to identify intrinsic collective motions
of the molecule. In this model, the biomolecule is mod-
elled as a harmonic oscillator with every residue repre-
sented as a single site, connected by springs to nearby
residues [73]. The oGNM web server [75] calculates low
frequency normal modes for the unbound structure
based on GNM. In GNM, the motions are isotropic by
definition, thereby predicting only regions exhibiting in-
trinsic motion and magnitude of change. The direction-
ality of motion cannot be predicted using GNM models.
The server constructs the elastic network model of the
structure by considering each of the Cα atoms as a node
and identifying all interacting nodes using a distance
cut-off of 10 Å. The six most low frequency modes were
analyzed to check whether any of the ‘non-interacting
regions with PB change’ far away from the interface
show probable biologically relevant intrinsic motion.
Determining the extent of conservation of
non-interacting residues with conformational changes
xBased on the assumption that evolutionary conserva-
tion of a site in a protein family is an indicator of its
functional relevance and/or structural integrity, the de-
gree of conservation of all sites in a protein family was
calculated using the Jensen-Shannon divergence meas-
ure. This metric operates on the premise that most sites
in a protein family are not under any evolutionary pres-
sure and hence have a distribution similar to background
amino acid distribution. Sites under evolutionary pres-
sure, such as functional or stabilizing sites, show amino
acid distribution significantly different from the back-
ground distribution.
Homologous sequences for every protein in our PPC
dataset were identified by a search employing PSI-BLAST
[110] against the UNIREF90 [111] database at an e-value
cutoff of 0.0001 for 3 iterations. Further, only sequences
with ≥30% identity were considered. A multiple sequence
alignment (MSA) of the query sequence with only the
aligned regions of the homologous sequences was gener-
ated using CLUSTALW. The conservation scores for every
site in the MSA was calculated using Jensen-Shannon diver-
gence measure [112]. The sites with top 30% conservationscores are considered to be well conserved [112] and sites
with bottom 30% conservation scores are considered to be
poorly conserved.
Generation of symmetry-related molecules using PyMOL
Symmetry-related molecules were generated for the
bound and unbound molecule using PyMOL [77].
The crystal packing after generation of symmetry-
related molecules was checked to ascertain if any
crystal packing could cause the observed structural
changes in a complex.
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